A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Columbia University Medical Center (21+ years), New York

Columbia University Medical Center (≤21 years), New York

Children's Hospital of Philadelphia, Philadelphia

The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers, Nashville

St. Jude Children's Research Hospital, Memphis

Ann & Robert Lurie Children's Hospital of Chicago, Chicago

University of Illinois at Chicago Hospitals and Health Systems, Chicago

Methodist Children's Hospital/Texas Transplant Institute, San Antonio

Lucile Packard Children's Hospital of Stanford University, Palo Alto

Hopital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels

The Hospital for Sick Children, Toronto

Hopital Necker Enfants Malades, Paris

University Hospital Duesseldorf, Düsseldorf

Regensburg University Hospital, Clinic and Polyclinic for Paediatric and Adolescent Medicine, Paediatric Haemotology, Oncology and Stem Cell Transplantation, Regensburg

Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica Ospedale Pediatrico Bambino Gesu - IRCCS, Rome

Imperial College Healthcare NHS Trust, Hammersmith Hospital, London

Royal London and St Bartholomew's Hospital, Pathology and Pharmacy Building, London